Other News Releases in Health Care & Hospitals
Congressman Fattah: Thanks to Specter, Casey for a Major Step Along History's Path
Patient Files Suit Against St. Vincent's Hospital in New York City as a Result of the Alleged Use by the Hospital of an HIV Infected Device During a Routine Procedure
Leading Anti-Abortion Group Vows to Vigorously Fight the Senate Health Bill
Other News Releases in Legal Issues
Patient Files Suit Against St. Vincent's Hospital in New York City as a Result of the Alleged Use by the Hospital of an HIV Infected Device During a Routine Procedure
U.S. Court of Appeals Upholds AstraZeneca AWP Settlement
Axiant to be Purchased by NCO Group
Journalists and Bloggers
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
See more news releases in: Health Care & Hospitals, Medical Pharmaceuticals, Supplementary Medicine, General Sports, Legal Issues
USADA Orders LNDD To Deny Floyd Landis' Observer Access To 'B' Sample Retesting
Retesting Conducted Without Independent Observer Oversight
NEW YORK and PARIS, April 23 /PRNewswire/ -- Under the order of the
United States Anti-Doping Agency (USADA) Paul Scott, expert consultant to
2006 Tour de France champion Floyd Landis and observer at the illegal
retesting of Landis' already cleared Tour de France samples, was yesterday
denied entry to the Laboratoire National de Depistage du Dopage (LNDD) at
Chatenay-Malabry. As such, the analysis of two samples was conducted
without a Landis representative as witness. Such behavior constitutes a
clear and direct infringement of Landis' rights while casting severe doubt
on the integrity of an already dubious process.
This latest incident comes on the heels of a week in which Landis'
observers have been repeatedly and improperly restricted from accessing key
phases of data processing and analysis while USADA's expert and lawyer were
able to have free lab access and directed the retesting process of LNDD.
Per the pre-arbitration process, there was to be an independent expert
appointed by the arbitration panel whose role was to determine if the
testing methodologies are flawed and to provide an additional degree of
protection for Landis. USADA knowingly directed that the testing begin
April 16 despite the fact that no such expert had been named.
According to Scott, LNDD lab director Jacques de Ceaurriz did not allow
him to enter the facility Sunday morning. Ceaurriz cited direct orders from
USADA to prohibit any further observation of the ongoing retesting.
During the analysis, USADA observers regularly provided specific
direction to the LNDD, over-ruling the Landis observers' objections and
conferring with LNDD staff in private during sample processing. Landis and
his team find this behavior to be particularly troubling as these
deliberate actions confirm their position that the samples have been
subject to mishandling, further malfeasance and potential results
falsification.
Scott, former director of client services at the UCLA Olympic
Laboratory, left UCLA last October and shortly thereafter was added as a
consultant to the Landis defense team. Early on, Scott cited the poor
handling of Landis' Stage 17 sample as the primary example of the deep
problems in scientific method and fact finding in this case.
Scott said, "In my years at the UCLA lab, I've never seen anything like
what I experienced at the LNDD yesterday. The limitation placed on me and
Simon [Davis - an Isotope Ratio Mass Spectometry expert also selected by
Landis to observe the retesting] demonstrates the lack of objectivity in
this process, USADA's interest in controlling and limiting our observation
of the retesting is an example of one of the most egregious problems in the
fundamental science of anti-doping that I have experienced."
Given the indisputable conflicts and documented incompetence at the
LNDD, testing Landis' "B" samples there without witness or Panel appointed
independent expert highlights USADA's out-of-control prosecution. The
outrageous and improper limitations placed on Landis' observers reinforce
the injustice inherent to this entire process. This is particularly evident
in the case of this unprecedented retesting, where both USADA and the LNDD
have a vested interest in colluding to corroborate the flawed results of
Landis' Stage 17 sample.
Scott added, "Good science does not fear being an open book. Any
science that is not neutral and objective is not science at all. Labs
acting under the direction of prosecuting Anti-Doping Organizations (ADOs)
are, by definition, not independent. As service providers hired by ADOs,
they have a vested interest in the results desired by their client. In this
case, the client is USADA and the lab is the LNDD. From what I have
witnessed so far, I have significant concerns that their analysis will
render results that are scientifically invalid."
By exhausting sample material during the retesting without providing
the checks and balances necessary to protect the interests of the athlete,
USADA has willfully destroyed evidence that can be used to independently
verify whatever results come out of the conflicted LNDD facility.
"This is yet another in a series of malicious actions by USADA that
tramples my right to have my case heard in fair and just way," said Landis.
"How can I be expected to prove my innocence while USADA endeavors to break
their own rules at every turn? I'm infuriated by the behavior of USADA and
the LNDD. Together, they have turned this proceeding into a full-scale
attack on my civil rights and a mockery of justice."
SOURCE Floyd Fairness Fund













